| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| fostamatinib | ap2-associated protein kinase 1 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | tyrosine-protein kinase abl1 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | abelson tyrosine-protein kinase 2 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | activin receptor type-1 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | activin receptor type-1b | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | adenosine receptor a3 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | antagonist |
| fostamatinib | alk tyrosine kinase receptor | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | arachidonate 5-lipoxygenase | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | ankyrin repeat and protein kinase domain-containing protein 1 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | aurora kinase a | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | aurora kinase b | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | aurora kinase c | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | tyrosine-protein kinase receptor ufo | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | tyrosine-protein kinase blk | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | bmp-2-inducible protein kinase | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | bone morphogenetic protein receptor type-1b | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | bone morphogenetic protein receptor type-2 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | cytoplasmic tyrosine-protein kinase bmx | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | serine/threonine-protein kinase b-raf | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | tyrosine-protein kinase btk | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | calcium/calmodulin-dependent protein kinase type 1 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | calcium/calmodulin-dependent protein kinase type 1d | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | calcium/calmodulin-dependent protein kinase type 1g | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | calcium/calmodulin-dependent protein kinase type ii subunit alpha | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | calcium/calmodulin-dependent protein kinase type ii subunit beta | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | calcium/calmodulin-dependent protein kinase type ii subunit delta | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | calcium/calmodulin-dependent protein kinase type ii subunit gamma | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | calcium/calmodulin-dependent protein kinase kinase 1 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | calcium/calmodulin-dependent protein kinase kinase 2 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | peripheral plasma membrane protein cask | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | serine/threonine-protein kinase mrck gamma | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | cyclin-dependent kinase 1 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | cyclin-dependent kinase 15 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | cyclin-dependent kinase 16 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | cyclin-dependent kinase 17 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | cyclin-dependent kinase 4 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | cyclin-dependent kinase-like 1 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | cyclin-dependent kinase-like 2 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | serine/threonine-protein kinase chk1 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | serine/threonine-protein kinase chk2 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | citron rho-interacting kinase | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | clip-associating protein 1 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | dual specificity protein kinase clk1 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | dual specificity protein kinase clk2 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | dual specificity protein kinase clk3 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | dual specificity protein kinase clk4 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | atypical kinase coq8a, mitochondrial | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | atypical kinase coq8b, mitochondrial | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | macrophage colony-stimulating factor 1 receptor | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | tyrosine-protein kinase csk | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | kappa-casein | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | casein kinase i isoform alpha | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | casein kinase ii subunit alpha | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | casein kinase ii subunit alpha' | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | cathepsin l1 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | cathepsin s | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | death-associated protein kinase 1 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | death-associated protein kinase 2 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | death-associated protein kinase 3 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | serine/threonine-protein kinase dclk1 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | serine/threonine-protein kinase dclk2 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | serine/threonine-protein kinase dclk3 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | epithelial discoidin domain-containing receptor 1 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | discoidin domain-containing receptor 2 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | dual specificity tyrosine-phosphorylation-regulated kinase 1a | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | dual specificity tyrosine-phosphorylation-regulated kinase 1b | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | epidermal growth factor receptor | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | eukaryotic translation initiation factor 2-alpha kinase 1 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | interferon-induced, double-stranded rna-activated protein kinase | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | eif-2-alpha kinase gcn2 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | ephrin type-a receptor 1 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | ephrin type-a receptor 2 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | ephrin type-a receptor 3 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | ephrin type-a receptor 4 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | ephrin type-a receptor 5 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | ephrin type-a receptor 6 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | ephrin type-a receptor 7 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | ephrin type-a receptor 8 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | ephrin type-b receptor 1 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | ephrin type-b receptor 2 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | ephrin type-b receptor 4 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | ephrin type-b receptor 6 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | receptor tyrosine-protein kinase erbb-2 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | receptor tyrosine-protein kinase erbb-4 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | serine/threonine-protein kinase/endoribonuclease ire1 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | fatty-acid amide hydrolase 1 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | tyrosine-protein kinase fer | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | tyrosine-protein kinase fes/fps | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | fibroblast growth factor receptor 1 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | fibroblast growth factor receptor 2 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | fibroblast growth factor receptor 3 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | tyrosine-protein kinase fgr | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | vascular endothelial growth factor receptor 1 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | receptor-type tyrosine-protein kinase flt3 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | vascular endothelial growth factor receptor 3 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | tyrosine-protein kinase frk | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | tyrosine-protein kinase fyn | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | cyclin-g-associated kinase | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | glycogen synthase kinase-3 alpha | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | glycogen synthase kinase-3 beta | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | tyrosine-protein kinase hck | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | homeodomain-interacting protein kinase 2 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | homeodomain-interacting protein kinase 3 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | serine/threonine-protein kinase ick | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | inhibitor of nuclear factor kappa-b kinase subunit beta | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | inhibitor of nuclear factor kappa-b kinase subunit epsilon | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | insulin receptor | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | insulin receptor-related protein | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | interleukin-1 receptor-associated kinase 1 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | interleukin-1 receptor-associated kinase 3 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | interleukin-1 receptor-associated kinase 4 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | tyrosine-protein kinase itk/tsk | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | tyrosine-protein kinase jak1 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | tyrosine-protein kinase jak2 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | tyrosine-protein kinase jak3 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | vascular endothelial growth factor receptor 2 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | mast/stem cell growth factor receptor kit | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | serine/threonine-protein kinase lats1 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | tyrosine-protein kinase lck | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | lim domain kinase 1 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | lim domain kinase 2 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | leucine-rich repeat serine/threonine-protein kinase 2 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | leukocyte tyrosine kinase receptor | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | tyrosine-protein kinase lyn | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | dual specificity mitogen-activated protein kinase kinase 2 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | dual specificity mitogen-activated protein kinase kinase 3 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | dual specificity mitogen-activated protein kinase kinase 5 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | dual specificity mitogen-activated protein kinase kinase 6 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | mitogen-activated protein kinase kinase kinase 1 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | mitogen-activated protein kinase kinase kinase 10 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | mitogen-activated protein kinase kinase kinase 11 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | mitogen-activated protein kinase kinase kinase 12 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | mitogen-activated protein kinase kinase kinase 13 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | mitogen-activated protein kinase kinase kinase 15 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | mitogen-activated protein kinase kinase kinase 19 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | mitogen-activated protein kinase kinase kinase 2 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | mitogen-activated protein kinase kinase kinase 3 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | mitogen-activated protein kinase kinase kinase 4 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | mitogen-activated protein kinase kinase kinase 6 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | mitogen-activated protein kinase kinase kinase 9 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | mitogen-activated protein kinase kinase kinase kinase 1 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | mitogen-activated protein kinase kinase kinase kinase 2 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | mitogen-activated protein kinase kinase kinase kinase 3 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | mitogen-activated protein kinase kinase kinase kinase 4 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | mitogen-activated protein kinase kinase kinase kinase 5 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | mitogen-activated protein kinase 10 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | mitogen-activated protein kinase 13 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | mitogen-activated protein kinase 14 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | mitogen-activated protein kinase 15 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | mitogen-activated protein kinase 4 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | mitogen-activated protein kinase 7 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | mitogen-activated protein kinase 9 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | map kinase-activated protein kinase 5 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | serine/threonine-protein kinase mark1 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | serine/threonine-protein kinase mark2 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | map/microtubule affinity-regulating kinase 3 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | map/microtubule affinity-regulating kinase 4 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | microtubule-associated serine/threonine-protein kinase 1 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | megakaryocyte-associated tyrosine-protein kinase | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | maternal embryonic leucine zipper kinase | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | tyrosine-protein kinase mer | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | hepatocyte growth factor receptor | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | misshapen-like kinase 1 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | map kinase-interacting serine/threonine-protein kinase 1 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | map kinase-interacting serine/threonine-protein kinase 2 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | macrophage-stimulating protein receptor | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | serine/threonine-protein kinase mtor | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | muscle, skeletal receptor tyrosine-protein kinase | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | myosin light chain kinase, smooth muscle | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | myosin light chain kinase 2, skeletal/cardiac muscle | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | myosin light chain kinase 3 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | myosin light chain kinase family member 4 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | myosin-iiia | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | serine/threonine-protein kinase nek1 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | serine/threonine-protein kinase nek11 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | serine/threonine-protein kinase nek2 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | serine/threonine-protein kinase nek3 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | serine/threonine-protein kinase nek4 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | serine/threonine-protein kinase nek5 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | serine/threonine-protein kinase nek9 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | serine/threonine-protein kinase nim1 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | high affinity nerve growth factor receptor | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | bdnf/nt-3 growth factors receptor | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | nt-3 growth factor receptor | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | nuak family snf1-like kinase 1 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | nuak family snf1-like kinase 2 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | serine/threonine-protein kinase osr1 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | serine/threonine-protein kinase pak 1 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | serine/threonine-protein kinase pak 2 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | serine/threonine-protein kinase pak 3 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | serine/threonine-protein kinase pak 4 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | serine/threonine-protein kinase pak 5 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | serine/threonine-protein kinase pak 6 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | cgmp-specific 3',5'-cyclic phosphodiesterase | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | platelet-derived growth factor receptor alpha | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | platelet-derived growth factor receptor beta | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | 3-phosphoinositide-dependent protein kinase 1 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | phosphatidylinositol 4-kinase beta | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | phosphatidylinositol 4-phosphate 3-kinase c2 domain-containing subunit beta | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | phosphatidylinositol 4-phosphate 3-kinase c2 domain-containing subunit gamma | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | serine/threonine-protein kinase pim-1 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | serine/threonine-protein kinase pim-3 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | phosphatidylinositol 5-phosphate 4-kinase type-2 beta | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | phosphatidylinositol 5-phosphate 4-kinase type-2 gamma | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | serine/threonine-protein kinase n1 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | serine/threonine-protein kinase n2 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | serine/threonine-protein kinase plk1 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | serine/threonine-protein kinase plk2 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | serine/threonine-protein kinase plk3 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | serine/threonine-protein kinase plk4 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | 5'-amp-activated protein kinase catalytic subunit alpha-1 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | 5'-amp-activated protein kinase | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | 5'-amp-activated protein kinase | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | 5'-amp-activated protein kinase | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | 5'-amp-activated protein kinase | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | camp-dependent protein kinase catalytic subunit alpha | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | camp-dependent protein kinase catalytic subunit beta | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | 5'-amp-activated protein kinase | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | 5'-amp-activated protein kinase | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | 5'-amp-activated protein kinase | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | protein kinase c delta type | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | protein kinase c epsilon type | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | protein kinase c gamma type (prkcg) | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | protein kinase c iota type | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | protein kinase c theta type | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | serine/threonine-protein kinase d1 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | cgmp-dependent protein kinase 2 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | serine/threonine-protein kinase prp4 homolog | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | focal adhesion kinase 1 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | protein-tyrosine kinase 2-beta | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | protein-tyrosine kinase 6 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | raf proto-oncogene serine/threonine-protein kinase | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | proto-oncogene tyrosine-protein kinase receptor ret | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | serine/threonine-protein kinase rio1 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | serine/threonine-protein kinase rio2 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | serine/threonine-protein kinase rio3 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | receptor-interacting serine/threonine-protein kinase 1 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | receptor-interacting serine/threonine-protein kinase 2 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | receptor-interacting serine/threonine-protein kinase 4 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | rho-associated protein kinase 2 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | proto-oncogene tyrosine-protein kinase ros | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | ribosomal protein s6 kinase alpha-1 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | ribosomal protein s6 kinase alpha-3 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | ribosomal protein s6 kinase alpha-6 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | serine/threonine-protein kinase sbk1 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | uncharacterized serine/threonine-protein kinase sbk3 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | serine/threonine-protein kinase sgk3 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | serine/threonine-protein kinase sik1 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | serine/threonine-protein kinase sik2 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | serine/threonine-protein kinase sik3 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | equilibrative nucleoside transporter 1 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | ste20-like serine/threonine-protein kinase | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | snf-related serine/threonine-protein kinase | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | proto-oncogene tyrosine-protein kinase src | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | tyrosine-protein kinase srms | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | serine/threonine-protein kinase 10 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | serine/threonine-protein kinase 16 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | serine/threonine-protein kinase 17a | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | serine/threonine-protein kinase 17b | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | serine/threonine-protein kinase 24 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | serine/threonine-protein kinase mst4 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | serine/threonine-protein kinase 3 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | serine/threonine-protein kinase 32a | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | serine/threonine-protein kinase 33 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | serine/threonine-protein kinase 35 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | serine/threonine-protein kinase 36 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | serine/threonine-protein kinase 38 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | serine/threonine-protein kinase 38-like | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | ste20/sps1-related proline-alanine-rich protein kinase | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | tyrosine-protein kinase syk | small molecule | Successful target | TTD , drugbank , DGIDB | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
6.37 | approved,investigational | inhibitor |
| fostamatinib | serine/threonine-protein kinase tao1 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | serine/threonine-protein kinase tao2 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | serine/threonine-protein kinase tao3 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | serine/threonine-protein kinase tbk1 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | tyrosine-protein kinase tec | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | angiopoietin-1 receptor | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | dual specificity testis-specific protein kinase 1 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | tgf-beta receptor type-1 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | tgf-beta receptor type-2 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | tyrosine-protein kinase receptor tie-1 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | serine/threonine-protein kinase tousled-like 1 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | serine/threonine-protein kinase tousled-like 2 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | traf2 and nck-interacting protein kinase | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | non-receptor tyrosine-protein kinase tnk1 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | activated cdc42 kinase 1 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | serine/threonine-protein kinase tnni3k | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | testis-specific serine/threonine-protein kinase 1 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | dual specificity protein kinase ttk | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | tyrosine-protein kinase txk | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | non-receptor tyrosine-protein kinase tyk2 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | tyrosine-protein kinase receptor tyro3 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | udp-glucuronosyltransferase 1-1 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | serine/threonine-protein kinase ulk1 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | serine/threonine-protein kinase ulk2 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | serine/threonine-protein kinase ulk3 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | vesicular monoamine transporter 2 (vmat2) | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | wee1-like protein kinase | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | tyrosine-protein kinase yes | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | mitogen-activated protein kinase kinase kinase mlt | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| fostamatinib | tyrosine-protein kinase zap-70 | small molecule | NA | drugbank | Immune thrombocytopenic purpura[MeSHID:D016553] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | approved,investigational | inhibitor |
| click here to return to the previous page | ||||||||